The interaction of the antineoplastic drug thalicarpine with aniline hydroxylase and microsomal cytochrome of rat liver.
D000814:Aniline Compounds; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001060:Aporphines / Q000494:pharmacology*; D002467:Cell Nucleus / Q000378:metabolism; D065607:Cytochrome P-450 Enzyme Inhibitors; D003579:Cytochrome Reductases / Q000037:antagonists & inhibitors; D003574:Cytochrome c Group; D003580:Cytochromes / Q000037:antagonists & inhibitors*; D004247:DNA / Q000378:metabolism; D066298:In Vitro Techniques; D007546:Isoquinolines / Q000494:pharmacology*; D008297:Male; D008748:Methylcholanthrene / Q000494:pharmacology; D008862:Microsomes, Liver / Q000187:drug effects / Q000201:enzymology*; D006899:Mixed Function Oxygenases / Q000037:antagonists & inhibitors*; D009249:NADP; D012313:RNA / Q000378:metabolism; D051381:Rats; D013997:Time Factors
D000814:Aniline Compounds; D000970:Antineoplastic Agents; D001060:Aporphines; D065607:Cytochrome P-450 Enzyme Inhibitors; D003574:Cytochrome c Group; D003580:Cytochromes; D007546:Isoquinolines; D009249:NADP; D008748:Methylcholanthrene; D012313:RNA; D004247:DNA; D006899:Mixed Function Oxygenases; D003579:Cytochrome Reductases